Spending Less Time Watching TV Could Cut Coronary Heart Disease Risk
Watching too much TV is associated with an increased risk of coronary heart disease regardless of a person’s genetic makeup, according research published today in the journal BMC Medicine.
Leading cause of death
Coronary heart disease is one of the UK’s leading causes of death, responsible for around 64,000 deaths each year.
In the UK, one in eight men and one in 15 women die from the disease. Being physically inactive is one of the major risk factors for coronary heart disease.
Risks associated with sedentary lifestyle
Compared to these individuals, people who watched two to three hours of TV a day had a relative 6 per cent lower rate of developing the condition, while those who watched less than an hour of TV had a relative 16 per cent lower rate.
These associations were independent of genetic susceptibility and other known risk factors. Leisure time spent using a computer did not appear to influence disease risk.
“While it can be difficult to weave physical activity into our daily routines, it only takes 150 minutes of moderate intensity exercise each week to help reduce your risk of developing heart and circulatory diseases.
“When the temptation hits you to watch one more episode, try standing up and stretching, or go for an evening stroll instead. Stopping evening snacks and ensuring you eat a healthy balanced diet can also give your heart health a boost.”
People In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more